Oxford Nanopore sells £42.5m share in headquarters
Oxford-based sequencing tech firm Oxford Nanopore has sold a stake in its headquarters, the Gosling Building, for £42.5 million.
Oxford Nanopore are a privately-owned company headquartered at the Oxford Science Park, with satellite offices in Cambridge (UK & US), New York and Shanghai. They were founded in 2005 to develop an electronic single-molecule sensing system based on nanopore science.
Nanopore science uses nano-scale holes embedded in high-tech electronics to perform precise molecular analysis.
Read more - Oxford Nanopore's sequencing picked for comprehensive US human genome project
The company makes electronics-based DNA/RNA sequencing technology which is used in more than 70 countries. Its equipment has a range of applications, including large scale human genomics, cancer research, microbiology, plant science and environmental research.
Following the sale, Oxford Science Park will immediately grant Oxford Nanopore an occupational lease of the property for 10 years, at a rent of £1.8 million per annum.
Chief Financial Officer Tim Cowper said: "We are pleased to have agreed the sale and leaseback of our headquarters building. The proceeds will be used for continued development of our core business."
Read more - Oxford Nanopore names new non-executive chair
